InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free INM Stock Alerts $0.23 -0.02 (-8.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media InMed Pharmaceuticals Short Interest DataCurrent Short Volume114,500 sharesPrevious Short Volume10,300 sharesChange Vs. Previous Month+1,011.65%Dollar Volume Sold Short$36,491.15Short Interest Ratio / Days to Cover0.3Last Record DateApril 15, 2024Outstanding Shares6,060,000 sharesPercentage of Shares Shorted1.89%Today's Trading Volume478,442 sharesAverage Trading Volume756,841 sharesToday's Volume Vs. Average63% Short Selling InMed Pharmaceuticals ? Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINM Short Interest Over TimeINM Days to Cover Over TimeINM Percentage of Float Shorted Over Time Ad Paradigm PressBiden out June 13; Kamala won’t replace him?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. InMed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024114,500 shares $36,491.15 +1,011.7%N/A0.3 $0.32 3/31/202410,300 shares $3,749.20 -81.9%N/A0 $0.36 3/15/202457,000 shares $20,520.00 -13.9%N/A0.3 $0.36 2/29/202466,200 shares $27,473.00 -52.1%N/A0.3 $0.42 2/15/2024138,300 shares $47,990.10 +244.9%N/A0.7 $0.35 1/31/202440,100 shares $14,431.99 -43.4%N/A0.2 $0.36 Get the Latest News and Ratings for INM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/202470,800 shares $27,081.00 -47.2%N/A0 $0.38 12/31/2023134,000 shares $55,744.00 +1,213.7%N/A0.1 $0.42 12/15/202310,200 shares $3,672.00 -65.9%N/A0 $0.36 11/30/202329,900 shares $13,156.00 +510.2%N/A0 $0.44 11/15/20234,900 shares $1,989.40 -74.1%N/A0 $0.41 10/31/202318,900 shares $9,143.82 +339.5%N/A0 $0.48 10/15/20234,300 shares $2,743.40 +377.8%N/A0 $0.64 9/30/2023900 shares $629.91 -90.1%N/A0 $0.70 9/15/20239,100 shares $7,683.13 -65.4%N/A0.2 $0.84 8/31/202326,300 shares $21,592.30 +64.4%N/A0.5 $0.82 8/15/202316,000 shares $14,961.60 -61.5%N/A0.2 $0.94 7/31/202341,500 shares $46,480.00 +112.8%N/A0.5 $1.12 7/15/202319,500 shares $18,721.95 +2.6%N/A0.2 $0.96 6/30/202319,000 shares $17,480.00 -63.2%N/A0.2 $0.92 6/15/202351,600 shares $65,532.00 +4.7%N/A0.4 $1.27 5/31/202349,300 shares $66,062.00 -24.0%N/A0.1 $1.34 5/15/202364,900 shares $75,284.00 -30.8%N/A0.1 $1.16 4/30/202393,800 shares $112,560.00 -25.7%N/A0.2 $1.20 4/15/2023126,300 shares $157,875.00 +3.8%N/A0.2 $1.25 3/31/2023121,700 shares $131,436.00 -27.7%N/A0.2 $1.08 3/15/2023168,400 shares $178,504.00 +194.9%N/A0.2 $1.06 2/28/202357,100 shares $75,943.00 -15.8%N/A0.1 $1.33 2/15/202367,800 shares $113,226.00 -7.6%N/A0.1 $1.67 1/31/202373,400 shares $135,056.00 -75.4%N/A0.1 $1.84 1/15/2023297,800 shares $562,842.00 +443.4%3.8%0.3 $1.89 12/30/202254,800 shares $110,696.00 +13.0%0.7%0.1 $2.02 12/15/202248,500 shares $90,210.00 +62.8%0.6%0.1 $1.86 11/30/202229,800 shares $78,970.00 +223.9%0.4%0 $2.65 11/15/20229,200 shares $25,576.00 -32.9%0.1%0 $2.78 10/31/202213,700 shares $41,785.00 +121.0%0.2%0 $3.05 10/15/20226,200 shares $32,922.00 -83.9%0.1%0 $5.31 9/30/202238,600 shares $254,516.82 -57.3%0.5%0 $6.59 9/15/202290,300 shares $867,783.00 +12,800.0%1.2%0.1 $9.61 8/31/2022700 shares $4,165.00 -89.4%N/A0 $5.95Biden out June 13; Kamala won’t replace him? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. INM Short Interest - Frequently Asked Questions What is InMed Pharmaceuticals' current short interest? Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 114,500 shares of INM short. Learn More on InMed Pharmaceuticals' current short interest. Is InMed Pharmaceuticals' short interest increasing or decreasing? InMed Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 114,500 shares, an increase of 1,011.7% from the previous total of 10,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InMed Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to InMed Pharmaceuticals: 180 Life Sciences Corp. (3.30%), NeuBase Therapeutics, Inc. (0.81%), PainReform Ltd. (2.95%), Galmed Pharmaceuticals Ltd. (2.21%), Bio-Path Holdings, Inc. (3.64%), Panbela Therapeutics, Inc. (2.36%), Lucy Scientific Discovery Inc. (1.69%), GRI Bio, Inc. (0.61%), Qualigen Therapeutics, Inc. (0.91%), Clearmind Medicine Inc. (5.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short InMed Pharmaceuticals stock? Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InMed Pharmaceuticals? A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further. How often is InMed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Interest NeuBase Therapeutics Short Interest PainReform Short Interest Galmed Pharmaceuticals Short Interest Bio-Path Short Interest Panbela Therapeutics Short Interest Lucy Scientific Discovery Short Interest GRI Bio Short Interest Qualigen Therapeutics Short Interest Clearmind Medicine Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INM) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryWhy Big Pharma is Investing Billions in This BiotechBehind the Markets